BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3331702)

  • 1. Activation of 2-amino-3-methylimidazo (4,5-f) quinoline in rat and human hepatocyte/Salmonella mutagenicity assays: the contribution of hepatic conjugation.
    Paterson P; Chipman JK
    Mutagenesis; 1987 Mar; 2(2):137-40. PubMed ID: 3331702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the mutagenic effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) in bacteria with rat-liver 9000 x g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Brunborg G; Alexander J; Trygg B; Bjørnstad C
    Mutat Res; 1988 Jan; 197(1):39-49. PubMed ID: 3275882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
    Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
    Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the food mutagens IQ and MeIQ by hepatic S9 fractions derived from various species.
    Alldrick AJ; Rowland IR
    Mutat Res; 1985 Oct; 144(2):59-62. PubMed ID: 3900706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activity of three synthetic isomers of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the Ames test.
    Vikse R; Klungsøyr L; Grivas S
    Mutat Res; 1993 Dec; 319(4):273-8. PubMed ID: 7504200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-aminofluorene for bacterial mutagenesis by primary monolayer cultures of adult rat hepatocytes.
    Gayda DP; Pariza MW
    Mutat Res; 1983 Jul; 118(1-2):7-14. PubMed ID: 6346088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic acetylation and sulfation of N-hydroxyarylamines in bacteria and rat livers.
    Yamazoe Y; Abu-Zeid M; Gong DW; Staiano N; Kato R
    Carcinogenesis; 1989 Sep; 10(9):1675-9. PubMed ID: 2670304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline.
    Hao NJ; Huang MP; Lee H
    Mutat Res; 1995 May; 328(2):183-91. PubMed ID: 7739602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ.
    Morrison LD; Eling TE; Josephy PD
    Mutat Res; 1993 May; 302(1):45-52. PubMed ID: 7683106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical structure and mutagenic activity of aminoimidazoquinolines and aminonaphthimidazoles related to 2-amino-3-methylimidazo[4,5-f]quinoline.
    Kaiser G; Harnasch D; King MT; Wild D
    Chem Biol Interact; 1986 Jan; 57(1):97-106. PubMed ID: 3512112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatic conversion of some heterocyclic amines to bacterial mutagens is modified by dietary fat and cholesterol.
    Alldrick AJ; Rowland IR; Wise A
    Mutagenesis; 1987 May; 2(3):221-4. PubMed ID: 3325747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The food pyrolysis product IQ enhances its own activation.
    Ayrton AD; Williams EJ; Rodrigues AD; Ioannides C; Walker R
    Mutagenesis; 1989 May; 4(3):205-7. PubMed ID: 2659938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential mutagenic activity of IQ (2-amino-3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium strains in vitro and in vivo, in Drosophila, and in mice.
    Wild D; Gocke E; Harnasch D; Kaiser G; King MT
    Mutat Res; 1985; 156(1-2):93-102. PubMed ID: 3923347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
    Edenharder R; Rauscher R; Platt KL
    Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity of the food mutagen 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and analogs.
    Barnes WS; Lovelette CA; Tong C; Williams GM; Weisburger JH
    Carcinogenesis; 1985 Mar; 6(3):441-4. PubMed ID: 3884172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).
    Wolz E; Wild D; Degen GH
    Arch Toxicol; 1995; 69(3):171-9. PubMed ID: 7717873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar patterns of DNA adduct formation of 2-amino-3-methylimidazo [4,5-f]quinoline in the Fischer 344 rat, CDF1 mouse, cynomolgus monkey and Salmonella typhimurium.
    Schut HA; Snyderwine EG; Zu HX; Thorgeirsson SS
    Carcinogenesis; 1991 May; 12(5):931-4. PubMed ID: 2029759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.